Health Affairs January Issue is Now Available
Health Affairs Today released the latest issue of their journal Health Affairs. The issue features a wide range of topics [...]
‘It is legal extortion’: Diabetics pay steep price for insulin as rebates drive up costs
In 1921, Canadian scientist Frederick Banting discovered insulin and later sold the patent to the University of Toronto for $1, [...]
2022 forecast: With omicron extending the pandemic, how will biopharma respond to COVID?
2022 forecast: With omicron extending the pandemic, how will biopharma respond to COVID? kdunleavy Mon, 12/20/2021 - 21:28 Read the [...]
ISPOR’s HEOR Competencies Framework™ for HEOR Professionals
ISPOR presents a new tool to help employers and educators train health economics and outcomes research (HEOR) professionals. Their HEOR [...]
Rubio-Klobuchar Bill to Deny Seniors Daily Medications Backed By PhRMA
WASHINGTON , Dec. 20, 2021 /PRNewswire/ -- Legislation introduced late last week by Senators Amy Klobuchar (MN) and Marco Rubio [...]
Florida Demands 30,000 Covid-19 Antibody Doses As Hospitals Across U.S. Scramble To Secure Life-Saving Treatment
Florida Gov. Ron DeSantis demanded between 30,000 and 40,000 doses of Covid-19 monoclonal antibody treatment Monday despite research showing that [...]
‘Enough Is Enough’: Outrage as Big Pharma Celebrates 2022 by Hiking Prices on 442 Drugs
Patient advocates on Monday condemned the U.S. pharmaceutical industry for ushering in the new year with price hikes on more [...]
Drug Prices Haven’t Been Going Up – Wsj
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs [...]
ISPOR: Attracting Candidates with Top Talent
The demand for Health Economics and Outcomes Research (HEOR) experts has increased as the field has risen to increased prominence [...]
Democrats’ effort to cap insulin prices faces Republican opposition
WASHINGTON – Democrats promise they’ll soon fix a problem that has tormented diabetics for years – the soaring price of [...]
Drug price controls are essential for small businesses
As small businesses across the country buckle up for another possible winter of COVID-19, they suffered an avoidable blow in [...]
The price of curing cancer
- Research - Open Access - [Published:] The price of curing cancer 1328 (2021) [Cite this article](#citeas) 8 Accesses - [...]
Manager, Value & Evidence Strategy (Remote) | HealthEconomics
Are you looking to make a difference in a patient’s life? At AmerisourceBergen, you will find an innovative and collaborative [...]
S1_E12: Dr. Shrividya Iyer, Executive Director, Oncology Global Real World Evidence (RWE) & US HEOR, Eisai
Dr. Shrividya Iyer is a health care researcher currently working on cancer health outcomes research, with a key focus on [...]
Survey, Whitepaper from PrognosⓇ Health and Reuters Events™ Uncovers RWD Trends in the Pharmaceutical Industry
NEW YORK--(BUSINESS WIRE)--Dec 9, 2021-- Prognos Health recently partnered with ReutersEvents to survey brand, commercial strategy, and data science leaders [...]
Leading Pharma Company Brings Products to Market Faster with Datatron’s MLOps and AI Governance Solution
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px [...]
Focussing on pharma’s blind spot
Industry’s free pass to its target audience has been shredded by the pandemic leaving the sales force compass struggling to [...]
Frontiers Health Digital Innovators: Aptar’s Sai Shankar
Continuing his Frontiers Health Digital Innovator’s series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. [...]
Post-Brexit medicines regulation must have international scope
Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left [...]
Mind the gap: Are you delivering what HCPs value or what you want them to have?
Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of [...]
Deep Dive: Digital Health 2021
There is no doubt that the COVID-19 pandemic has accelerated the adopt of digital health. As this issue’s contributors discuss, [...]
Creating an effective patient engagement set of practices that is enduring and future-proof
For the past ten years we’ve seen a steady acceptance of the need for patient engagement practises to become routine [...]
Regulation optimisation could save thousands of life years
Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across the European [...]
Leveraging augmented analytics to drive better business decisions
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was [...]
Drug development and working with specialised Rare Disease networks
There are currently an estimated 300 million people living with one or more Rare Diseases across the world. There are [...]